新希望(000876.SZ)上半年預虧29.5億元-34.5億元
格隆匯7月15日丨新希望(000876.SZ)披露2021年半年度業績預吿,公司預計2021年1-6月實現歸屬於上市公司股東的淨利潤為虧損29.50億元-34.50億元,上年同期為盈利31.64億元。
與去年同期相比,報吿期內生豬銷售價格大幅下降,疊加飼料原料價格上漲及疫情影響等因素,生豬養殖成本上升,導致豬產業虧損是報吿期經營業績虧損的主要原因。
另外,由於市場豬價較年初發生了較大幅度下跌,公司根據企業會計準則和謹慎性的要求,對目前存欄的消耗性生物資產按照成本與可變現淨值孰低的原則做了減值測試,計提了10億元左右的存貨跌價準備。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.